Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.

scientific article published in May 1998

Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0735-1097(98)00083-7
P698PubMed publication ID9581716
P5875ResearchGate publication ID13701800

P2093author name stringMiller M
Pearson TA
Seidler A
Moalemi A
P2860cites workIncreased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterolQ33896856
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studiesQ34496492
Hypertriglyceridemic Very Low Density Lipoproteins Induce Triglyceride Synthesis and Accumulation in Mouse Peritoneal MacrophagesQ36985479
Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart diseaseQ39241018
The effects of antihypertensive drugs on serum lipids and lipoproteins, I. DiureticsQ39743407
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patientsQ42556657
Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical eventsQ43891430
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.Q44689759
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.Q44759552
Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).Q45208371
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatinQ46176091
Hyperlipoproteinemia and pancreatitisQ48014923
Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.Q50926556
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.Q51603418
Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.Q51621111
Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load.Q51633932
Long-term prognosis after myocardial infarction in men with diabetes.Q52664903
Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase GeneQ57840093
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosisQ57840099
The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterolQ61785739
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart AssociationQ66912818
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatmentQ67720940
Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster studyQ68037615
Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery diseaseQ70595052
Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetesQ71102944
Serum triglycerides in health and in ischemic heart diseaseQ72559601
Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosisQ72791703
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupQ73804303
Serum triglycerides in coronary artery diseaseQ78455521
Influence of myocardial infarction on plasma-lipoprotein concentrationQ78705437
Are we mortgaging the medical profession?Q95814757
P433issue6
P407language of work or nameEnglishQ1860
P921main subjecttriglycerideQ186319
coronary artery diseaseQ844935
P304page(s)1252-1257
P577publication date1998-05-01
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleNormal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.
P478volume31

Reverse relations

cites work (P2860)
Q34145532A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans
Q37262617Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Q37035456Age- and sex-related changes in fasting plasma glucose and lipoprotein in cynomolgus monkeys
Q44451305An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia
Q44559866Antihypertriglyceridemic effect of walnut oil.
Q92547414Association between normal triglyceride and insulin resistance in US adults without other risk factors: a cross-sectional study from the US National Health and Nutrition Examination Survey, 2007-2014
Q34107165Combination drug therapy for dyslipidemia.
Q40393652Coronary heart disease in women: what do we know now?
Q33835502Dietitian intervention improves lipid values and saves medication costs in men with combined hyperlipidemia and a history of niacin noncompliance
Q34262629Differentiating the effects of raising low levels of high-density lipoprotein cholesterol versus lowering normal triglycerides: further insights from the Veterans Affairs High-Density Lipoprotein Intervention Trial
Q32063032Distribution and cardiovascular risk correlates of serum triglycerides in young adults from a biracial community: the Bogalusa Heart Study
Q51552229Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet.
Q32063040Diurnal triglyceride profiles: a novel approach to study triglyceride changes
Q37143825Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?
Q46199518Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids
Q44311057Effect of desirable fasting triglycerides on the postprandial response to dietary fat.
Q31919769Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production
Q51457652Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance.
Q85181665Effects of a diet with inulin-enriched pasta on gut peptides and gastric emptying rates in healthy young volunteers
Q37328559Effects of feeding periods of high cholesterol and saturated fat diet on blood biochemistry and hydroxyproline fractions in rabbits
Q44007594Epidemiology of hypertriglyceridemia and cardiovascular disease
Q34071541Evidence that triglycerides are an independent coronary heart disease risk factor
Q51298164Fasting Lipoprotein Lipase Protein Levels Can Predict a Postmeal Increment of Triglyceride Levels in Fasting Normohypertriglyceridemic Subjects.
Q44536731Fasting and daylong triglycerides in obesity with and without type 2 diabetes
Q44054654Frequency of postprandial lipemia after a first acute coronary event (unstable angina pectoris or non-ST-segment elevation acute myocardial infarction) and the effects of atenolol on the lipemia
Q77463131Gender differences in diurnal triglyceridemia in lean and overweight subjects
Q37997627Genetically modified pigs for biomedical research.
Q33972829Giving triglycerides their due.
Q51369235Hemostatic effects of bezafibrate and ω-3 fatty acids in isolated hypertriglyceridemic patients.
Q41480218High postprandial triglycerides serum levels: is obesity a good predictor?
Q43913029Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity
Q30244825Hypertriglyceridemia: the importance of identifying patients at risk
Q33580249Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease
Q33646056Impact of dyslipidaemia. Lessons from clinical trials
Q44341495Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease
Q36569199Interlinkage among cardio-metabolic disease markers in an urban poor setting in Nairobi, Kenya
Q34084615Introduction: low-saturated fat, high-carbohydrate diets: effects on triglyceride and LDL synthesis, the LDL receptor, and cardiovascular disease risk
Q44173620Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers.
Q44621116Life Style and Cardiovascular Risk Factors in the Japanese Population-From an Epidemiological Survey on Serum Lipid Levels in Japan 1990. Part 1: Influence of Life Style and Excess Body Weight on HDL-Cholesterol and Other Lipid Parameters in Men
Q44621121Life Style and Cardiovascular Risk Factors in the Japanese Population-From an Epidemiological Survey on Serum Lipid Levels in Japan 1990. Part 2: Association of Lipid Parameters with Hypertension
Q36070412Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis
Q35203793Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment
Q35101119Management of patients with diabetic hyperlipidemia
Q33843614Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation
Q35108901Nutrition for health promotion: phytochemicals, functional foods, and alternative approaches to combat obesity
Q34129395Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter
Q79762017Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids
Q33918549Pharmacodynamics of oestrogens and progestogens
Q34003407Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment
Q34418506Psoriasis and comorbidities: links and risks
Q46386834Psoriasis and dyslipidemia: a population-based study analyzing the National Health and Nutrition Examination Survey (NHANES).
Q33646061Resource utilisation in the management of dyslipidaemia
Q31942452Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia
Q52538514Serum neopterin and complex stenosis morphology in patients with unstable angina.
Q28208349Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism
Q44272184Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes
Q94278550Sugar
Q28199120The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element
Q38056160The association between psoriasis and dyslipidaemia: a systematic review
Q33748893The changes in various hydroxyproline fractions in aortic tissue of rabbits are closely related to the progression of atherosclerosis
Q35332645The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia
Q33665230The epidemiology of triglyceride as a coronary artery disease risk factor
Q58271154The metabolic syndrome and cardiovascular disease
Q37308002The role of triglycerides in cardiovascular risk
Q44469664Triglyceride as a risk factor, epidemiology
Q34027254Triglycerides and coronary risk
Q34418028Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease.
Q46727396Walnut consumption in hyperlipidemic patients.

Search more.